{"id":773797,"date":"2023-07-31T12:49:38","date_gmt":"2023-07-31T16:49:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/"},"modified":"2023-07-31T12:49:38","modified_gmt":"2023-07-31T16:49:38","slug":"tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/","title":{"rendered":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform<\/b><\/p>\n<p>SAN FRANCISCO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftivichealth.com&amp;esheet=53490435&amp;newsitemid=20230731542904&amp;lan=en-US&amp;anchor=Tivic+Health%26%23174%3B+Systems%2C+Inc.&amp;index=1&amp;md5=2e84f85b88643adf167a99187d949624\">Tivic Health<sup>\u00ae<\/sup> Systems, Inc.<\/a> (\u201cTivic\u201d, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that the U.S. Patent and Trademark Office has issued its sixth patent for its bioelectronic platform, expanding the Company\u2019s intellectual property to include the proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery.<\/p>\n<p>\n\u201cThis patent issuance continues to build the strength of our intellectual property portfolio,\u201d says Jennifer Ernst, CEO of Tivic. \u201cBioelectronic medicine is an important treatment methodology for the future and Tivic is delivering innovative solutions to meet consumer needs.\u201d<\/p>\n<p>\nThe company has an additional 17 patents pending in the U.S. and abroad. The patents already issued address device specifications, comfort features, device performance during treatment, and future product developments. This new patent US 11642523 addresses the core technology used to deliver bioelectronic treatment to the user.<\/p>\n<p>\nTivic\u2019s first commercial product, ClearUP, is an over the counter bioelectronic device that is FDA approved for treating symptoms of inflammation such as sinus pain and congestion.<\/p>\n<p><b>About Tivic<\/b><\/p>\n<p>\nTivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic\u2019s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Tivic\u2019s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic\u2019s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Ftivichealth.com&amp;esheet=53490435&amp;newsitemid=20230731542904&amp;lan=en-US&amp;anchor=http%3A%2F%2Ftivichealth.com&amp;index=2&amp;md5=56ebdb105afcd492092e4af10be10fd2\">http:\/\/tivichealth.com<\/a> @TivicHealth<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p><i>This press release may contain \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d \u201cwill\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.\u2019s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.<\/i><i>Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: <\/i><i>market and other conditions; supply chain constraints; macroeconomic factors, including inflation; and unexpected costs, charges or expenses that reduce Tivic\u2019s capital resources. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Tivic\u2019s actual results to differ from those contained in the forward-looking statements, see Tivic\u2019s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 31, 2023, under the heading \u201cRisk Factors\u201d; as well as the company\u2019s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230731542904\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230731542904\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Kayleigh Westerfield<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Kayleigh.Westerfield@tivichealth.com\">Kayleigh.Westerfield@tivichealth.com<\/a><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Hanover International, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@tivichealth.com\">ir@tivichealth.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Technology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230731542904\/en\/1740047\/3\/Tivic_Logo_400x400.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that the U.S. Patent and Trademark Office has issued its sixth patent for its bioelectronic platform, expanding the Company\u2019s intellectual property to include the proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. \u201cThis patent issuance continues to build the strength of our intellectual property portfolio,\u201d says Jennifer Ernst, CEO of Tivic. \u201cBioelectronic medicine is an important treatment methodology for the future and Tivic is delivering innovative solutions to meet consumer needs.\u201d The company has an additional 17 patents pending in the U.S. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-773797","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that the U.S. Patent and Trademark Office has issued its sixth patent for its bioelectronic platform, expanding the Company\u2019s intellectual property to include the proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. \u201cThis patent issuance continues to build the strength of our intellectual property portfolio,\u201d says Jennifer Ernst, CEO of Tivic. \u201cBioelectronic medicine is an important treatment methodology for the future and Tivic is delivering innovative solutions to meet consumer needs.\u201d The company has an additional 17 patents pending in the U.S. &hellip; Continue reading &quot;Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-31T16:49:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform\",\"datePublished\":\"2023-07-31T16:49:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/\"},\"wordCount\":637,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/\",\"name\":\"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-07-31T16:49:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/","og_locale":"en_US","og_type":"article","og_title":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk","og_description":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that the U.S. Patent and Trademark Office has issued its sixth patent for its bioelectronic platform, expanding the Company\u2019s intellectual property to include the proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. \u201cThis patent issuance continues to build the strength of our intellectual property portfolio,\u201d says Jennifer Ernst, CEO of Tivic. \u201cBioelectronic medicine is an important treatment methodology for the future and Tivic is delivering innovative solutions to meet consumer needs.\u201d The company has an additional 17 patents pending in the U.S. &hellip; Continue reading \"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-31T16:49:38+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform","datePublished":"2023-07-31T16:49:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/"},"wordCount":637,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/","name":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-07-31T16:49:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230731542904r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-expands-ip-protection-with-issuance-of-sixth-patent-for-its-bioelectronic-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/773797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=773797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/773797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=773797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=773797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=773797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}